Deerfield, Illinois, Feb. 27, 2025 (GLOBE NEWSWIRE) -- DEERFIELD, IL. February 27, 2025 – Vantage Specialty Chemicals, Inc., (Vantage) today announced that its VYCERIN™ API Glycerin, USP is listed on ...

Learn how softgels have helped sponsors across the industry improve the efficacy and stability of their therapeutics.

Inhaled drug formulation involves consideration of multiple factors, including the properties of the API, the needs of the target patient population, the delivery requirements, and the choice of ...

Drug developers are now frequently tasked with designing oral products for molecules with low solubility and low permeability ...

Oral liquid drugs play a vital role for patients who have difficulty swallowing tablets and for those requiring personalised ...

The antibiotics active pharmaceutical ingredient (API) market plays a crucial role in the global healthcare ecosystem. APIs are the core components in the formulation of antibiotics that are essential ...

The Europe pharmaceutical CDMO market size is calculated at USD 37.98 billion in 2025 and is expected to reach around USD ...

ANKLESHWAR, India--(BUSINESS WIRE)--RUSAN PHARMA PRIVATE LIMITED, a pharmaceutical company based in India specializing in the area of addiction treatment and pain management, recently announced that ...

Contract Secured in Preparation for Pivotal Trial & Expected Launch of Jaguar's Prescription Drug Candidate, Canalevia, for Acute Diarrhea in Dogs Jaguar to Leverage Patheon's Experience Manufacturing ...

Vantage Specialty Chemicals, Inc., (Vantage) today announced that its VYCERIN™ API Glycerin, USP is listed on the Drug Master File (DMF-040171) with the U.S. Food and Drug Administration (FDA).